ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Passage Bio Inc

Passage Bio Inc (PASG)

0.89
-0.12
(-11.88%)
마감 04 12월 6:00AM
0.89
0.00
(0.00%)
시간외 거래: 9:30AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
0.89
매수가
0.89
매도가
0.9281
거래량
600,358
0.88 일간 변동폭 1.04
0.451 52주 범위 1.79
market_cap
전일 종가
1.01
개장가
0.965
최근 거래 시간
2300
@
0.89
(formt)
마지막 거래 시간
재정 규모
US$ 567,675
VWAP
0.94556
평균 볼륨(3m)
551,101
발행 주식
61,767,286
배당수익률
-
주가수익률
-0.54
주당순이익(EPS)
-1.65
매출
-
순이익
-102.06M

Passage Bio Inc 정보

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
본부
Wilmington, Delaware, USA
설립됨
-
Passage Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker PASG. The last closing price for Passage Bio was US$1.01. Over the last year, Passage Bio shares have traded in a share price range of US$ 0.451 to US$ 1.79.

Passage Bio currently has 61,767,286 shares in issue. The market capitalisation of Passage Bio is US$62.38 million. Passage Bio has a price to earnings ratio (PE ratio) of -0.54.

PASG 최신 뉴스

Passage Bio Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

Enrolled 4 patients in Cohort 2 of the upliFT-D trial for FTD-GRN, with patient dosing advancing as planned; 12-month Cohort 1 and interim Cohort 2 data expected in 1H25 Updated interim data from...

Passage Bio to Present at Guggenheim Securities Healthcare Innovation Conference

PHILADELPHIA , Nov. 06, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on improving the lives of patients with neurodegenerative...

Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Conference

Preclinical data demonstrated that an AAV1 vector achieved superior human progranulin levels in the CSF as compared to AAV5 and AAVhu68 (an AAV9 variant) Nonclinical data showed PBFT02 improved...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.259941.24742104430.63011.330.630145610431.09340319CS
40.2845.90163934430.611.330.45111955510.98962189CS
120.228.98550724640.691.330.4515511010.8868064CS
26-0.19-17.59259259261.081.330.4513738160.86883455CS
520.223433.51335133510.66661.790.4514175030.98432982CS
156-6.82-88.45654993517.717.810.4513286891.67401249CS
260-21.38-96.003592276622.2738.230.4513185627.14082625CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ZJKZJK Industrial Company Ltd
US$ 17.185
(171.06%)
28.21M
CTNTCheetah Net Supply Chain Service Inc
US$ 4.81
(157.22%)
113.16M
ORISOriental Rise Holdings Ltd
US$ 11.11
(69.10%)
1.47M
JYDJayud Global Logistics Ltd
US$ 1.1299
(68.62%)
10.8M
GWAVGreenwave Technology Solutions Inc
US$ 0.6078
(66.52%)
512.32M
REVBRevelation Biosciences Inc
US$ 0.504151
(-46.93%)
6.08M
OMEXOdyssey Marine Exploration Inc
US$ 0.4201
(-43.63%)
4.88M
RITRReitar Logtech Holdings Ltd
US$ 2.68
(-38.39%)
1.25M
XCURExicure Inc
US$ 14.05
(-37.00%)
433.62k
AGFYAgrify Corporation
US$ 32.72
(-36.69%)
285.46k
GWAVGreenwave Technology Solutions Inc
US$ 0.6078
(66.52%)
512.32M
SMCISuper Micro Computer Inc
US$ 40.21
(-4.26%)
204.35M
NVDANVIDIA Corporation
US$ 140.26
(1.18%)
164.82M
INTCIntel Corporation
US$ 22.47
(-6.10%)
138.16M
CHRSCoherus BioSciences Inc
US$ 1.7001
(24.09%)
115.07M

PASG Discussion

게시물 보기
PonkenPlonken PonkenPlonken 15 시간 전
Wedbush pump losing steam
the dilemma is the readouts are right around the corner
👍️0
Stumblebum Stumblebum 4 일 전
Next week should be interesting….will Pasg hold its gains or tank…was it a pump and dump day…..15 million share volume today …..massive increase …..hmmmmm
👍️0
PonkenPlonken PonkenPlonken 5 일 전
EVERYTHING the analyst said today was well known.
Direct CNS delivery... AAV gene therapy pioneer thinks AAV gene therapy will work in FTD too.... First one of its kind in FTD.... Then in recent months we got about a million validations of that ---------- No one bit this? They didnt believe him? Because he left again for head of gene therapy at PENNs and then went on to found 2 new companies instead of linger around at PASG at 60 something years?
No one believed he gave the steering wheel to Mr Chou because Wilson thought Chou could finish the job?
👍️0
PonkenPlonken PonkenPlonken 5 일 전
Analyst says most basic stuff and they go crazy?
👍️0
PonkenPlonken PonkenPlonken 7 일 전
will it keep going?
👍️0
PonkenPlonken PonkenPlonken 4 월 전
big pop coming. Science hated for no reason. Founder is gene therapy authority. AAV tech works.
👍️0
Monksdream Monksdream 4 월 전
PASG 10Q due AUGUST5
👍️0
PonkenPlonken PonkenPlonken 4 월 전
See the first rally on this after the big bar on the first data release. They saw something and took a seat. A lot of shares were bought. Thats because the platform works and will -- veeery surprisingly -- produce great data.
👍️0
PonkenPlonken PonkenPlonken 4 월 전
this is not a daytrade. I am invested here, waiting for the crowd/data.
I think a deal is coming on data release.... its a neglected approach. Founder is a genius and gene therapy authority, popularized AAVs. All the recent bio winners use them.
Happy trading
👍️0
Awl416 Awl416 4 월 전
Ahem..
👍️0
PonkenPlonken PonkenPlonken 4 월 전
Going to explode on the next readout

Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
Agency feedback from Type C meeting process supports the company's proposed clinical development plans to expand the upliFT-D trial to assess PBFT02 in FTD patients with C9orf72 gene mutations


👍️0
Monksdream Monksdream 5 월 전
There are close to 1,000 listed med tech companies
Only so many can garner serious institutional interest
👍️0
PonkenPlonken PonkenPlonken 5 월 전
I wonder... when will people realize that the AAV stuff is great... CADL, SLDB, PASG

The founder certainly thinks so... and he is the authority on the topic:
"Dr. James M. Wilson serves as the Director of the Gene Therapy Program (GTP) at Penn's Perelman School of Medicine."

"The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy.The Wilson lab identified a new type of vector based on novel isolates of adeno-associated viruses which have become best in class for gene therapy. More recently Dr. Wilson’s laboratory has focused on improved vectors for gene therapy and clinical applications of genome editing and mRNA therapy."
👍️0
Monksdream Monksdream 6 월 전
PASG under $2
👍️0
Monksdream Monksdream 7 월 전
PASG under $2
👍️0
Sirpeter Sirpeter 9 월 전
Running... boom!!!
👍️0
Monksdream Monksdream 9 월 전
PASG under $2
👍️0
glenn1919 glenn1919 9 월 전
PASG..........................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 월 전
PASG new 52 week high
👍️0
TrendTrade2016 TrendTrade2016 9 월 전
PASG setting up nicely. Another beautiful call by the only true chartist around
👍️0
Sirpeter Sirpeter 9 월 전
Yup yup yup...
👍️0
TrendTrade2016 TrendTrade2016 9 월 전
PASG...NEXT CRDL
👍️0
glenn1919 glenn1919 9 월 전
PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 9 월 전
PASG..............................https://stockcharts.com/h-sc/ui?s=PASG&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 월 전
PASG under $2
👍️0
turning stone turning stone 10 월 전
As a new investor in PASG, I am looking forward to another high roller in the next number of years. I bought ARNA years ago at 1.90 and rode it out to $99/share when they were bought out by Phizer Pharm. I would like to have my 5 grandkids share the spoils on this one. With a multi-pipe line, a couple should make it to the end of the line with FDA approval. At the number of shares I purchased multiple times I can afford to run for the hills if a sudden disaster should hit this one. This company is 21 miles from my home and I will stop by shortly and have a sit down with their home-based PR. person. Good luck to all. You may also want to look at BLRX {BIO-Line Inc }










👍️0
Walter4 Walter4 12 월 전
Data readout should be incoming shortly
👍️ 1
Monksdream Monksdream 1 년 전
PASG new 52 week low
👍️0
catinhat catinhat 3 년 전
So...anybody out there? Thoughts on upcoming abstract, etc?

Recent long.
👍️0
dealerschool2006 dealerschool2006 4 년 전
PASG down from panic selling due to the pricing of its underwritten public offering of 7,000,000 shares of its common stock at a public offering price of $22.00 per share.
👍️0

최근 히스토리

Delayed Upgrade Clock